Dr. Reddy’s Laboratories Ltd has acquired an eminent portfolio of over-the-counter (OTC) brands in the cough-and-cold, pain, and dermatology categories. The company acquired six OTC brands from Ducere Pharma, including DOAN’S®, BUFFERIN®, NUPERCAINAL® Ointment, CRUEX® Nail Gel, COMTREX®, and MYOFLEX®....

Read more

  Dr. Nandu Gattu, Vice President, Drug Repurposing, Excelra. Hyderabad-based Excelra, Asia’s leading knowledge solutions company, has formed a collaboration with H.M. Pharma Consultancy (HMPC), a Austrian life science consulting enterprise, to jointly provide Drug repurposing services to Pharma and...

Read more

Quantel Medica, a global ophthalmic medical device company dedicated to developing leading technologies to improve the diagnosis and treatment of ocular diseases, has been awarded a €3 million competitive tender for ophthalmic laser equipment. Under the terms of a supply...

Read more

Dr. Reddy’s and TR-Pharm has announced a strategic collaboration agreement involving 3 biosimilar products. A total of three products will be registered and subsequently commercialized as a part of this agreement by TR-Pharm in Turkey. TR-Pharm will also manufacture the drug...

Read more

Manipal Hospitals is the first hospital in India to install Masimo Patient SafetyNet™, a remote monitoring and clinician notification system. “With Patient SafetyNet, we are now able to monitor a certain set of patients 24x7,” said Gopal Devanahalli, Chief Operating...

Read more

India’s Ideal Cures Pvt. Ltd, a global company, manufacturer, global supplier and provider of technical support for pharmaceutical coatings and excipients, has set up a representative office in the United States. It has appointed Dr. Kamlesh Oza, Ph. D. as...

Read more
Page 25 of 27 1 24 25 26 27